Discover our project website and follow us on X and LinkedIn.
Together with the kick-off of ALADDIN at the beginning of 2024, we have officially launched the digital communication channels of our project. You can find the key information about ALADDIN here, on our website – we particularly encourage you to follow the News page for insights regarding the progress of our project.
ALADDIN (Accelerated Discovery Nanobody Platform) aims at developing and bringing to the market a platform that improves the discovery of therapeutic nanobodies and their preclinical validation for human cancer. The project is funded in the EIC Pathfinder Open programme of the European Innovation Council and SMEs Executive Agency (EISMEA).
This project has received funding from the EIC Pathfinder programme 2023 of the European Innovation Council (EIC) under Grant Agreement#101130574. This result only reflects the author’s view, and the EU is not responsible for any use that may be made of the information it contains.
This project has received funding from the EIC Pathfinder programme 2023 of the European Innovation Council (EIC) under Grant Agreement#101130574. This result only reflects the author’s view, and the EU is not responsible for any use that may be made of the information it contains.
